Driehaus Capital Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-140,641
Closed -$8.41M 477
2020
Q2
$8.41M Sell
140,641
-104,243
-43% -$6.44M 0.2% 140
2020
Q1
$14.5M Buy
244,884
+6,482
+3% +$378K 0.49% 59
2019
Q4
$13.1M Buy
238,402
+60,723
+34% +$2.27M 0.35% 83
2019
Q3
$5.02M Buy
177,679
+9,783
+6% +$359K 0.16% 152
2019
Q2
$5.57M Buy
167,896
+9,026
+6% +$282K 0.17% 151
2019
Q1
$5.4M Sell
158,870
-7,367
-4% -$234K 0.2% 134
2018
Q4
$4.55M Sell
166,237
-82,389
-33% -$2.12M 0.19% 142
2018
Q3
$7.26M Buy
+248,626
New +$7.02M 0.22% 142

Other funds holding PRNB

Driehaus Capital Management's PRNB Position: Q3 2020 in Review

Driehaus Capital Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 140,641 shares — an estimated $8.41M sold.

Driehaus Capital Management first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $14.5M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Driehaus Capital Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Driehaus Capital Management sold 140,641 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $8.41M.
  • Driehaus Capital Management first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Driehaus Capital Management's Principia Biopharma Inc. Common Stock position peaked at $14.5M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Driehaus Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.